The U.S. Food and Drug Administration (FDA) announced today it Approved the first COVID-19 preventive vaccine for individuals 16 years of age and older.
The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine and will now be marketed as Comirnaty.
The Comirnaty vaccine is effective in preventing COVID-19, and potentially serious outcomes, including hospitalization and death, says the FDA.
First COVID-19 Vaccine Approved in the USA
Teens, Young Men Have Higher SARS-CoV-2 Infection Rates
Standardized infection ratios were lowest in children and in adults aged 70 years or older compared with overall population
COVID-19 Mortality Lower for Vaccinated Solid Organ Transplant Recipients
Second study shows increased risk for breakthrough COVID-19 infection and associated mortality for SOTRs versus general population
Pfizer-BioNTech COVID-19 Vaccine Receives Full FDA Approval
Prescribing information includes warning about risks for myocarditis and pericarditis, particularly in men younger than 40 years
No Permanent Lung Damage Observed After COVID-19 Recovery
No difference seen between lung parenchyma of COVID-19 survivors and controls in specimens from unrelated elective lung resections
Most Parents Plan to Send Children to In-Person Learning, Despite COVID-19
Survey revealed racial gap between parents’ preferences and safety concerns
Israeli Study Shows Pfizer Booster Gives Seniors Big Rise in Immunity
Israel approved booster shots for people aged 60 years and older late last month; the government lowered the age of eligibility to 40 years last week
Pentagon to Make COVID-19 Vaccination Mandatory for Military
Officials are preparing to issue guidance to require vaccination, although no exact timeline has been given
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized